Article Details
Retrieved on: 2021-02-10 07:07:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Xbrane Biopharma AB (publ)'s (STO:XBRANE) Intrinsic Value Is Potentially 28% Above Its Share Price. By: Simply Wall St. Published: February 10, 2021.
Article found on: simplywall.st
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here